Pharma Focus Europe

News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Pentixapharm Completes Acquisition of Glycotope's Target Discovery Division

Thursday, July 04, 2024

Pentixapharm AG a clinicalstage biotech company specializing in developing targeted radiopharmaceuticals for treating cancer has acquired Glycotope GmbHs target discovery business effective July st This acquisition includes a portfolio of preclinical...

Owkin Expands AI-Biotech Presence into Germany, Austria, and Switzerland to Enhance Research Acceleration

Wednesday, July 03, 2024

Owkin a prominent AIbiotech firm has expanded into the DACH region by forming partnerships with nine leading institutions These include Charit Universittsmedizin Berlin

Signet Therapeutics receives FDA IND approval for the first targeted therapy designed for Diffuse Gastric Cancer

Tuesday, July 02, 2024

Signet Therapeutics a biotech company specializing in organoid disease models and AI for targeted cancer therapy announced FDA approval of its Investigational New Drug application for sigx

Radionetics Oncology and Lilly Enter Strategic Agreement

Tuesday, July 02, 2024

Radionetics Oncology a biotechnology company focused on developing innovative small molecule radiopharmaceuticals for targeting G proteincoupled receptors to treat solid tumors has announced a strategic partnership with Eli Lilly and Company The coll...

Taurx Pharmaceuticals Has Applied for Marketing Authorisation in the UK for HMTM as an Alzheimer's Treatment

Monday, July 01, 2024

TauRx Pharmaceuticals Ltd has submitted a UK Marketing Authorisation Application for hydromethylthionine mesylate targeting mild cognitive impairment and mild

magazine-slider-img
cytiva